BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11214912)

  • 1. A transgenic model of a familial prion disease.
    Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
    Arch Virol Suppl; 2000; (16):103-12. PubMed ID: 11214912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.
    Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B; Harris DA
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5574-9. PubMed ID: 10805813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.
    Chiesa R; Piccardo P; Ghetti B; Harris DA
    Neuron; 1998 Dec; 21(6):1339-51. PubMed ID: 9883727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic models of prion disease.
    Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
    Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
    Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
    Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
    Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model of a familial prion disease.
    Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
    Clin Lab Med; 2003 Mar; 23(1):175-86. PubMed ID: 12733431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.
    Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA
    Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice.
    Li A; Piccardo P; Barmada SJ; Ghetti B; Harris DA
    EMBO J; 2007 Jun; 26(11):2777-85. PubMed ID: 17510630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein with an insertional mutation accumulates on axonal and dendritic plasmalemma and is associated with distinctive ultrastructural changes.
    Jeffrey M; Goodsir C; McGovern G; Barmada SJ; Medrano AZ; Harris DA
    Am J Pathol; 2009 Sep; 175(3):1208-17. PubMed ID: 19700753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
    Stewart RS; Piccardo P; Ghetti B; Harris DA
    J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein functions and dysfunction in prion diseases.
    Sakudo A; Ikuta K
    Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Models of Inherited PrP Prion Diseases.
    Watts JC; Prusiner SB
    Cold Spring Harb Perspect Med; 2017 Nov; 7(11):. PubMed ID: 28096244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.